Mirae Asset Global Etfs Holdings Ltd. Standard Biotools Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $47.1 Billion
- Q2 2025
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Standard Biotools Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 163,916 shares of LAB stock, worth $219,647. This represents 0.0% of its overall portfolio holdings.
Number of Shares
163,916
Previous 176,271
7.01%
Holding current value
$219,647
Previous $190,000
3.16%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding LAB
# of Institutions
166Shares Held
278MCall Options Held
34.9KPut Options Held
0-
Casdin Capital, LLC New York, NY76.1MShares$102 Million12.8% of portfolio
-
Viking Global Investors LP58.7MShares$78.6 Million0.22% of portfolio
-
Black Rock Inc. New York, NY21.8MShares$29.1 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA17MShares$22.8 Million0.0% of portfolio
-
Long Focus Capital Management, LLC San Juan, PR10.1MShares$13.5 Million0.56% of portfolio
About STANDARD BIOTOOLS INC.
- Ticker LAB
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 78,654,800
- Market Cap $105M
- Description
- Standard BioTools Inc. creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide. It offers analytical systems, such as Helios, a CyTOF system, as well as Hyperion imaging systems, Hyperion tissue imagers, and flow conductors; and assays and reagents, including Maxpar ...